ABSTRACT A definitive diagnosis of myocarditis requires right ventricular biopsy. Despite its specificity, however, right ventricular biopsy may lack sensitivity due to the focal nature of the disease. Because 
ditis,' the present study was performed to evaluate the applicability of this technique in the diagnosis of myocarditis. Three patients had left ventricular ejection fractions greater than 45% (two men, one woman). One patient presented with chest pain and electrocardiographic changes resembling an evolving myocardial infarction; normal coronary arteries and no evidence of spasm were demonstrated during emergency coronary cineangiography. Another presented with pericardial effusion, chest pain, and atrial fibrillation, and one had unexplained bisided congestive heart failure, a nonnal left ventricular ejection fraction, and hemodynamic findings consistent with constrictive versus restrictive physiology. The pericardiumn appeared normal on two-dimensional echocardiography and computed body tomography. AF= atrial fibrillation; AMAb = antimyosin antibody; CHF = congestive heart failure; CP = chest pain; eff = pericardial effusion; LVEF = left ventricular ejection fraction; Myoc = myocarditis; NSC = nonspecific change; VT = ventricular tachycardia; VF = ventricular fibrillation.
Methods
APrevious bout of biopsy-proven myocarditis.
BPatients with abnormal left ventricular ejection fractions who showed an improvement of 10% or more.
The remaining 20 (80%) presented with acute onset of heart failure. Heart failure was present for less than 1 year in three of the 20 in this group, and for less than 6 months in 17. Four of the 20 had had a previous episode of biopsy-proven myocarditis, and presented with another episode of heart failure and symptoms suggestive of relapse.
Transvenous right ventricular endomyocardial biopsy and pathologic evaluation. Patients underwent right ventricular endomyocardial biopsy through the right jugular vein as previously described.2' 8,9 Multiple biopsy specimens (usually six or seven, each measuring 1 to 3 mm in diameter) were obtained with a Caves-Schultz-Stanford bioptome. Three to four samples were immediately fixed by immersion in buffered 10% formalin for histologic study by light microscopy. One sample was placed in 2.5% buffered glutaraldehyde for electron microscopy, and one was snap-frozen for immunofluorescence studies. Paraffin sections were stained with hematoxylin and eosin, Masson trichrome, and Congo red. The frozen sample was sectioned and stained with hemotoxylin and eosin, and with toluidine blue. Sections of 1 ,um were cut from each of the specimens embedded in plastic and stained with toluidine blue.
Biopsy specimens were analyzed without knowledge of the projections with a thickness of approxinmately 1 cm1 (3 pixels).
Planar and SPECT antimiyosin images were interpreted directly fromi the computer video display by at least three observers who had no knowledge of the bitpsy results. We classified the results of radiolabeled antinmyosin cardiac imaging as positive or negative. A scan was classified as positive when focal or diffuse uptake of the tracer was present in the planar iniage and in at least two ot the three tonmographic reconstructions (figure 2). A scan was necative when no tracer uptake was denionstrated in cither planar or tonmographic images ( figure 3 ). or when faint uptake was present in the planar but was not confirmed in the SPECTI images.
Results
Antimyosin Fab was administered without untoward reaction in all subjects. The clinical scores and histologic, ventriculographic, and antin3yosin imaging results are listed in table 1.
Endomyocardial biopsy findings. Right ventricular biopsies were diagnostic for myocarditis in nine patients (32%), showed nonspecific changes in 13 (47%), and were normal in six (21%c).
Results of antimyosin imaging. Table 2 shows the correlation between results of right ventricular biopsy and antimyosin imaging. Results of`In-antimyosin imaging were positive in 17 patients (61 %) and negative in 11 (39%c ) . In all 17 patients with positive antimyosin scans, tracer uptake was heterogeneous within the left ventricle. All patients with biopsy-proven nmyocarditis had positive antimyosin scans. In addition, eight patients with no evidence of myocarditis on biopsy had positive antimyosin scans. Of these eight patients, the biopsy samples of five were classified as normal and three showed nonspecific change. The changes consisted of varying degrees of interstitial and/or replacement fibrosis and myocyte hypertrophy, but no evi-dence of inflammation. A negative antimyosin scan was obtained in 1 
Discussion
It would be highly desirable to have a noninvasive screening test for myocarditis that could identify those patients who should undergo endomyocardial biopsy.2 One noninvasive method, the gallium-67 scan, is helpful because an inflammatory cell infiltrate is a histopathologic feature of this disease. ''`Antimyosin scanning provides an opportunity for monitoring the Anterior other obligatory abnormality associated with myocarditis, myocardial necrosis.' Experimental and clinical studies previously demonstrated that antimyosin Fab was specific only for necrotic myocytes in which intracellular myosin was accessible to extracellular fluid. 3 4 In this study, a positive antimyosin scan was present in all patients with biopsy-proven myocarditis. Of equal importance, all patients who had a negative antimyosin scan also had a negative biopsy result.
Of particular interest are those eight patients who had no evidence of myocarditis on biopsy but who had positive scans. Could normal myocardial biopsies be the result of focal disease with consequent sampling Ons FIGURE 3. A negative antimyosin image. No tracer uptake is seen in either the planar images (top) or the coronal tomographic reconstruction (bottom). LAO = left anterior oblique projection. error? Spontaneous improvement is a feature of acute myocarditis.2' 12 A spontaneous substantial improvement in ejection fraction occurred in four of these eight patients. The improvement in left ventricular ejection fraction at the time of follow-up radionuclide ventriculography must have been independent of loading changes due to medical therapy, because none of these improved patients required therapy for heart failure at that time. Although these findings suggest that an underlying diagnosis of myocarditis may have been missed because of a sampling error or a failure to identify early myocyte necrosis by histologic criteria,1 a definitive characterization of this group will require longer term follow-up.
Results more difficult to explain are those of three of the 11 patients with negative biopsies and negative scans who also showed improvement in their ejection fractions. It may be possible that during the course of myocarditis both necrosis and inflammation may have resolved at the time the patient was studied, yet improvement of ventricular function lagged behind the resolution of tissue injury. Another possibility is that there are other forms of transient depression of ventricular function that are still not characterized.
Thus, antimyosin scintigraphy appears to be a reliable screening method for the evaluation of patients suspected of having myocarditis. A positive antimyosin scan indicates the need for endomyocardial biopsy to establish the histologic diagnosis. If the present results are confirmed in studies of a larger number of patients, it may be possible to avoid biopsy in patients who present with a negative scan.
